Literature DB >> 3926544

Early luteal serum progesterone concentrations are higher in pregnancy cycles.

J L Yovich, S C McColm, J M Yovich, P L Matson.   

Abstract

In a consecutive series of 167 patients reaching the stage of embryo transfer after in vitro fertilization and embryo transfer, 19 clinical pregnancies ensued. The serum progesterone (P) levels were significantly greater on the first and second (P less than 0.01) and third (P less than 0.05) postaspiration days for those who conceived. Higher circulating levels of P were achieved on days 1, 2, and 3 (P less than 0.05) by the daily injection of P, 50 mg in oil, given for 5 consecutive days, beginning immediately after follicle aspiration. Both pregnancy and nonpregnancy cycles demonstrated high circulating P levels, but the study implies that relatively higher levels are required for conception, and such levels can be achieved by the use of intramuscular P.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926544     DOI: 10.1016/s0015-0282(16)48733-9

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  5 in total

Review 1.  Luteal phase support for assisted reproduction cycles.

Authors:  Michelle van der Linden; Karen Buckingham; Cindy Farquhar; Jan A M Kremer; Mostafa Metwally
Journal:  Cochrane Database Syst Rev       Date:  2015-07-07

2.  Increased progesterone secretion and 3 beta-hydroxysteroid dehydrogenase activity in human cumulus cells by pregnenolone is limited to the high steroidogenic active cumuli.

Authors:  S Bar-Ami; H Gitay-Goren
Journal:  J Assist Reprod Genet       Date:  2000-09       Impact factor: 3.412

3.  A comparative, randomized study of three different progesterone support of the luteal phase following IVF/ET program.

Authors:  P G Artini; A Volpe; S Angioni; M C Galassi; C Battaglia; A R Genazzani
Journal:  J Endocrinol Invest       Date:  1995-01       Impact factor: 4.256

4.  Luteinizing response to human chorionic gonadotropin does not predict outcome in gonadotropin releasing hormone agonist-suppressed/human menopausal gonadotropin-stimulated in vitro fertilization (IVF) cycles.

Authors:  A S Penzias; F N Shamma; J N Gutmann; D B Seifer; A H DeCherney; G Lavy
Journal:  J Assist Reprod Genet       Date:  1992-06       Impact factor: 3.412

5.  Differences in the luteal phases after failed or successful in vitro fertilization and embryo replacement.

Authors:  B Lejeune; M Camus; J Deschacht; F Leroy
Journal:  J In Vitro Fert Embryo Transf       Date:  1986-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.